141 related articles for article (PubMed ID: 3888679)
21. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome.
Singh KB; Mahajan DK; Wortsman J
J Reprod Med; 1994 Oct; 39(10):805-8. PubMed ID: 7837128
[TBL] [Abstract][Full Text] [Related]
22. Altered balance between the 5 alpha-reductase and aromatase pathways of androgen metabolism during controlled ovarian hyperstimulation with human menopausal gonadotropins.
Slater CC; Chang L; Stanczyk FZ; Paulson RJ
J Assist Reprod Genet; 2001 Oct; 18(10):527-33. PubMed ID: 11699123
[TBL] [Abstract][Full Text] [Related]
23. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
Nestler JE; Powers LP; Matt DW; Steingold KA; Plymate SR; Rittmaster RS; Clore JN; Blackard WG
J Clin Endocrinol Metab; 1991 Jan; 72(1):83-9. PubMed ID: 1898744
[TBL] [Abstract][Full Text] [Related]
24. Partial reversal of the hypogonadotropic hypogonadism of obese men by administration of corticosuppressive doses of dexamethasone.
Zumoff B; Strain GW; Miller LK; Rosner W; Levit CD; Miller EH; Rosenfeld RS
Int J Obes; 1988; 12(6):525-31. PubMed ID: 3148562
[TBL] [Abstract][Full Text] [Related]
25. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.
Carmina E; Fruzzetti F; Lobo RA
Am J Obstet Gynecol; 2016 Jun; 214(6):714.e1-6. PubMed ID: 26767792
[TBL] [Abstract][Full Text] [Related]
26. Effect of peripheral sex steroid metabolism on pituitary gonadotropin reserve of women with hypothalamic amenorrhea.
Griffing G; Redline R; Jaffee W; Longcope C; Vaitukaitis J
Fertil Steril; 1981 Nov; 36(5):578-83. PubMed ID: 6796439
[TBL] [Abstract][Full Text] [Related]
27. Amenorrhea with cryptic hyperandrogenemia.
McKenna TJ; Moore A; Magee F; Cunningham S
J Clin Endocrinol Metab; 1983 May; 56(5):893-6. PubMed ID: 6833468
[TBL] [Abstract][Full Text] [Related]
28. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
29. Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease.
Paradisi R; Venturoli S; Pasquali R; Capelli M; Porcu E; Fabbri R; Flamigni C
J Endocrinol Invest; 1986 Apr; 9(2):139-44. PubMed ID: 3086422
[TBL] [Abstract][Full Text] [Related]
30. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
[TBL] [Abstract][Full Text] [Related]
31. Endocrine comparison of obese menstruating and amenorrheic women.
Zhang YW; Stern B; Rebar RW
J Clin Endocrinol Metab; 1984 Jun; 58(6):1077-83. PubMed ID: 6427258
[TBL] [Abstract][Full Text] [Related]
32. Circulating hormone levels in a case of granulosa cell tumor.
Wentz AC; McCranie WM
Fertil Steril; 1976 Feb; 27(2):167-70. PubMed ID: 765165
[TBL] [Abstract][Full Text] [Related]
33. Exaggerated gonadotropin response to luteinizing hormone-releasing hormone in amenorrheic runners.
Yahiro J; Glass AR; Fears WB; Ferguson EW; Vigersky RA
Am J Obstet Gynecol; 1987 Mar; 156(3):586-91. PubMed ID: 3548381
[TBL] [Abstract][Full Text] [Related]
34. Endocrinological meaning of hyperandrogenism in patients with polycystic ovary.
Takahashi K; Eda Y; Kusakari M; Yoshino K; Kitao M
Gynecol Obstet Invest; 1991; 31(1):46-50. PubMed ID: 2010114
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin responses to gonadotropin-releasing hormone and prolactin responses to thyrotropin-releasing hormone and metoclopramide in women with amenorrhea and insulin-treated diabetes mellitus.
Djursing H; Hagen C; Nyholm HC; Carstensen L; Andersen AN
J Clin Endocrinol Metab; 1983 May; 56(5):1016-21. PubMed ID: 6403566
[TBL] [Abstract][Full Text] [Related]
36. The effect of chronic and acyclic elevation of circulating androstenedione or estrone concentrations on ovarian function in the rhesus monkey.
Billiar RB; Richardson D; Anderson E; Mahajan D; Little B
Endocrinology; 1985 Jun; 116(6):2209-20. PubMed ID: 3922743
[TBL] [Abstract][Full Text] [Related]
37. Conversion of androgens to estrogens in idiopathic hemochromatosis: comparison with alcoholic liver cirrhosis.
Kley HK; Niederau C; Stremmel W; Lax R; Strohmeyer G; Krüskemper HL
J Clin Endocrinol Metab; 1985 Jul; 61(1):1-6. PubMed ID: 3998072
[TBL] [Abstract][Full Text] [Related]
38. Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.
Robin G; Gallo C; Catteau-Jonard S; Lefebvre-Maunoury C; Pigny P; Duhamel A; Dewailly D
J Clin Endocrinol Metab; 2012 Nov; 97(11):4236-43. PubMed ID: 22948766
[TBL] [Abstract][Full Text] [Related]
39. Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women.
Ho Yuen B; Mincey EK
Am J Obstet Gynecol; 1983 Jan; 145(2):152-7. PubMed ID: 6401396
[TBL] [Abstract][Full Text] [Related]
40. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene.
Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA
J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
